+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stimulating comprehensive medication reviews among Medicare Part D beneficiaries



Stimulating comprehensive medication reviews among Medicare Part D beneficiaries



American Journal of Managed Care 21(6): E372-E378



To assess the impact of a patient engagement intervention utilizing the Medication User Self-Evaluation (MUSE) tool on the completion percentage of comprehensive medication reviews (CMRs) among Medicare Part D beneficiaries. A case-control study. Beneficiaries from 2 Medicare Part D plans were randomly assigned to 3 study arms (1 control arm plus 2 intervention arms for 2011 and 2012, respectively). Each beneficiary who participated in the MUSE intervention met 3 inclusion criteria and was matched with a single control group beneficiary based on: gender; age (within 5-year interval); plan type (ie, Medicare Prescription Drug Plan, Medicare Advantage Prescription Drug Plan); number of unique prescriptions; pharmacy medication therapy management (MTM) training status; and time period (2011, 2012). The outcome of interest was whether or not the beneficiary received a CMR in the 6 months following the index date. Generalized estimating equation (GEE) models were used to compare CMR percentages over time and between MUSE intervention groups. This study used MTM service claims data. The final sample of 1015 beneficiaries received MUSE intervention, of which 1007 were successfully matched to a control beneficiary. The estimated odds of having a CMR among those who received the MUSE intervention were 2 times that of their counterparts (P = .0048) across both study years. Given the strong evidence found for a positive association between participation in a CMR and the MUSE intervention, Part D plans could use the MUSE to engage targeted beneficiaries in using pharmacist-provided MTM services.

(PDF emailed within 1 workday: $29.90)

Accession: 058905766

Download citation: RISBibTeXText

PMID: 26247578


Related references

Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews. Journal of the American Pharmacists Association 53(5): 482-487, 2014

Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population. Journal of Managed Care and Specialty Pharmacy 21(5): 381-389, 2016

Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population. Journal of Managed Care and Specialty Pharmacy 23(3): 388-394, 2017

Attitudes of Medicare beneficiaries toward pharmacist-provided medication therapy management activities as part of the Medicare Part D benefit. Journal of the American Pharmacists Association 47(6): 758-762, 2007

Centers for Medicare and Medicaid Services Support for Medication Therapy Management (Enhanced Medication Therapy Management): Testing Strategies for Improving Medication Use Among Beneficiaries Enrolled in Medicare Part D. Clinics in Geriatric Medicine 33(2): 153-164, 2018

The Effect Of Cost-Related Medication Nonadherence On The Decision Of Taking Up Medicare Part D Among Elderly Medicare Beneficiaries. Value in Health 18(3): A3-A4, 2015

The January effect: medication reinitiation among Medicare Part D beneficiaries. Health Economics 23(11): 1287-1300, 2015

Prevalence of chronic conditions among Medicare Part A beneficiaries in 2008 and 2010: are Medicare beneficiaries getting sicker?. Preventing Chronic Disease 11: 130118, 2015

Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D. American Journal of Geriatric Psychiatry 17(12): 1068-1076, 2010

Medication therapy management: a Medicare Part D benefit available to qualifying beneficiaries. South Dakota Medicine 60(3): 121, 2007

Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes. Medical Care 50(11): 913-919, 2013

Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes. Journal of Medical Economics 14(5): 562-567, 2012

Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes. Medical Care 51(2): 193-198, 2013

Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold. American Journal of Health-System Pharmacy 65(11): 1062-1070, 2008

The vast majority of Medicare Part D beneficiaries still don't choose the cheapest plans that meet their medication needs. Health Affairs 31(10): 2259-2265, 2013